June 16, 2023
January 25, 2025
This week’s newsletter included:
-
Denali, Alucent Present to Utah Life Sciences Innovation Caucus
-
Myriad Genetics Announces Research Collaboration to Use Minimal Residual Disease Testing Platform
-
Kuda Therapeutics Success Story Highlighted by Utah Innovation Center
-
Utah Business Announces 2023 CXOs of the Year
-
CancerVax Reports Positive Progress on Kids Cancer Immunotherapy Treatment
-
Purgo Scientific Named as One of 61 Startups in MedTech Accelerator 2023 Cohort
-
Recursion’s Phase 2 Trial for Treatment of Cerebral Cavernous Malformation Has Fully Enrolled
-
Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (Intranasal Carbetocin) for Prader-Willi Syndrome
-
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
-
CSBI Releases 2023 Life Sciences Workforce Trends Report
-
New Report Explores Best Practices in State Bioscience Economic Development
-
Ampleo Offers New Services – Fractional CMO
Recent News
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
- Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)